CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) |
12 Months Ended | |
|---|---|---|
Mar. 31, 2020 |
Mar. 31, 2019 |
|
| Details | ||
| Sales | $ 0 | $ 0 |
| Total Sales | 0 | 0 |
| Operating Expenses | ||
| Research and development | 302,328 | 60,332 |
| General and administrative | 110,550 | 137,224 |
| Impairment of property and equipment | 389,000 | 0 |
| Total Operating Expenses | 801,878 | 197,556 |
| Operating Loss | (801,878) | (197,556) |
| Interest expense | 0 | (120) |
| Loss before loss from discontinued operations | (801,878) | (197,676) |
| Discontinued operations | 6,858 | 0 |
| Net loss | $ (795,020) | $ (197,676) |
| Basic and Diluted Loss per Share - Continuing Operations | $ (0.01) | $ (0.00) |
| Basic and Diluted Loss per Share - Discontinued Operations | 0.00 | (0.00) |
| Basic and Diluted Loss per Share - Net Loss | $ (0.01) | $ (0.00) |
| Basic and Diluted Weighted-Average Common Shares Outstanding | 100,000,000 | 100,000,000 |